Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 6/20 | 0.57 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.50 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.50 |
| ▸ | QDPR | P09417 | 1/20 | 0.47 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.44 |
| ▸ | HTR3A | P46098 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.44 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.42 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.42 |
| ▸ | RAF1 | P04049 | 1/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27942946 | 0.98 | SLC18A3 (0.59) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL31401438 | 0.90 | SLC18A3 (0.52) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| SCHEMBL5042762 | 0.87 | HTR3A (0.60) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| SCHEMBL1189629 | 0.87 | HTR3A (0.60) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL5874037 | 0.85 | HTR3A (0.58) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL3543860 | 0.85 | HTR3A (0.58) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| Trifluoroacetic Acid SCHEMBL26600330 | 0.83 | HTR2C (0.54) | SLC18A3SIGMAR1HTR2CHRH3P2RY14 | |
| SCHEMBL1515255 | 0.83 | — | — | |
| Tert-Butyl Formate SCHEMBL27745536 | 0.80 | HTR2C (0.44) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 | |
| SCHEMBL25402303 | 0.79 | SLC18A3 (0.52) | SLC18A3SIGMAR1HTR2CMKNK1MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 604 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036599-A | Dibenzylbutane lignan LCA analogue, and preparation method and application thereof | 浙江中医药大学 | 2026-05-15 | — | — | CN | claimed |
| US-20240368088-A1 | EP4 ANTAGONIST COMPOUND AS WELL AS SALT, POLYMORPH AND USE THEREOF | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2024-11-07 | — | — | US | claimed |
| EP-4397654-A1 | EP4 ANTAGONIST COMPOUND AS WELL AS SALT, POLYMORPH, AND USE THEREOF | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2024-07-10 | — | — | EP | claimed |
| US-11932602-B2 | Method for preparing nicotinamide mononucleotide cocrystal | BONTAC BIO-ENGINEERING(SHENZHEN) CO., LTD (CN) | 2024-03-19 | — | — | US | claimed |
| US-20230263793-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIONS | MANENT TOMAS LLUIS (ES) | 2023-08-24 | — | — | US | claimed |
| EP-4199915-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIONS | MANENT TOMAS, Lluís (ES) | 2023-06-28 | — | — | EP | claimed |
| US-20220411376-A1 | METHOD FOR PREPARING NICOTINAMIDE MONONUCLEOTIDE COCRYSTAL | BONTAC BIO-ENGINEERING(SHENZHEN) CO.,LTD (CN) | 2022-12-29 | — | — | US | claimed |
| US-20220402961-A1 | NICOTINAMIDE MONONUCLEOTIDE-ISONICOTINE COCRYSTAL AND COMPOSITION THEREOF | ZHONGSHAN BONTAC BIO-TECHNOLOGY CO. , LTD (CN) | 2022-12-22 | — | — | US | claimed |
| CN-115246830-A | Solid form of acid and preparation method thereof | 广东东阳光药业有限公司 | 2022-10-28 | — | — | CN | claimed |
| CN-111574686-B | Star-shaped multi-response shape memory polyurethane composite material and preparation method thereof | 广东石油化工学院 | 2022-05-17 | — | — | CN | claimed |
| CN-104177308-A | Three novel febuxostat medicament eutectic crystals and preparation method thereof | UNIV ZHEJIANG CHINESE MEDICAL | 2014-12-03 | — | — | CN | claimed |
| CN-103864606-A | Eutectic of diflunisal and pyridine formamide compounds and preparation method thereof | SUZHOU INST NANO TECH & NANO B | 2014-06-18 | — | — | CN | claimed |
| CN-102503886-B | Agomelatine-isonicotine eutectic crystal and compound and preparation method thereof | UNIV SUN YAT SEN | 2013-09-11 | — | — | CN | claimed |
| CN-102093336-B | Method for extracting alkaloid by utilizing waste water and sludge of tobaccos | WUHAN DANYAXIANG TECH DEV CO | 2013-02-13 | — | — | CN | claimed |
| CN-102503886-A | Agomelatine-isonicotine eutectic crystal and compound and preparation method thereof | UNIV SUN YAT SEN | 2012-06-20 | — | — | CN | claimed |
| CN-102093336-A | Method for extracting alkaloid by utilizing waste water and sludge of tobaccos | WUHAN DANYAXIANG TECH DEV CO | 2011-06-15 | — | — | CN | claimed |
| CN-100569747-C | Sulfydryl-phenyl-naphthyl-methane Derivatives and preparation thereof | COUNCIL SCIENT IND RES (IN) | 2009-12-16 | — | — | CN | claimed |
| CN-1802348-A | Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof | COUNCIL SCIENT IND RES (IN) | 2006-07-12 | — | — | CN | claimed |
| US-5859008-A | Arylalkyl diazinones | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1999-01-12 | — | — | US | claimed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368088-A1 | EP4 ANTAGONIST COMPOUND AS WELL AS SALT, POLYMORPH AND USE THEREOF | PTGER4, PTGER1, PTGER2 | SLC18A3 4025/4885SIGMAR1 565/4885HTR2C 353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.